These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs. McCarthy DM Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039 [TBL] [Abstract][Full Text] [Related]
24. [Treatment and prevention of histamine-2 receptor antagonist for elderly gastric ulcer]. Kamada T; Sato Y; Shiotani A; Haruma K Nihon Rinsho; 2010 Nov; 68(11):2064-70. PubMed ID: 21061534 [TBL] [Abstract][Full Text] [Related]
25. [Current state and measures of NSAIDs induced ulcer]. Mizokami Y; Narasaka T; Suzuki H Nihon Rinsho; 2011 Oct; 69(10):1901-5. PubMed ID: 22073592 [TBL] [Abstract][Full Text] [Related]
26. Nonsteroidal anti-inflammatory drugs, Helicobacter pylori, and ulcers: where we stand. Graham DY Am J Gastroenterol; 1996 Oct; 91(10):2080-6. PubMed ID: 8855725 [TBL] [Abstract][Full Text] [Related]
27. [Prophylaxis and therapy of gastropathy caused by non-steroidal anti-inflammatory drugs]. László A Orv Hetil; 2002 Jul; 143(27):1643-8. PubMed ID: 12180001 [TBL] [Abstract][Full Text] [Related]
29. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs. Ray WA; Chung CP; Stein CM; Smalley WE; Hall K; Arbogast PG; Griffin MR Gastroenterology; 2007 Sep; 133(3):790-8. PubMed ID: 17854591 [TBL] [Abstract][Full Text] [Related]
30. [Prevention and treatment of NSAIDs-induced gastrointestinal complications by prostaglandin derivatives]. Suzuki Y; Saito E; Wakabayashi T; Suwa A Nihon Rinsho; 2007 Oct; 65(10):1843-9. PubMed ID: 17926534 [TBL] [Abstract][Full Text] [Related]
31. A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy. Yeomans ND Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S89-92. PubMed ID: 10379475 [TBL] [Abstract][Full Text] [Related]
32. [Pathologic condition and prognosis of NSAids ulcer]. Nishimura S; Uemura N Nihon Rinsho; 2011 Jun; 69(6):1003-6. PubMed ID: 21688619 [TBL] [Abstract][Full Text] [Related]
33. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios]. Limmer S; Ittel TH; Wietholtz H Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426 [TBL] [Abstract][Full Text] [Related]
34. NSAID-induced gastrointestinal damage. A critical review of prophylaxis and therapy. McCarthy DM J Clin Gastroenterol; 1990; 12 Suppl 2():S13-20. PubMed ID: 1978842 [TBL] [Abstract][Full Text] [Related]
36. Role of acid suppressants in prophylaxis of NSAID damage. Chan FK; Sung JJ Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):433-45. PubMed ID: 11403537 [TBL] [Abstract][Full Text] [Related]
37. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors. Lazzaroni M; Bianchi Porro G Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S73-8. PubMed ID: 10379473 [TBL] [Abstract][Full Text] [Related]
38. Nonsteroidal anti-inflammatory drugs: adverse effects and their prevention. Vonkeman HE; van de Laar MA Semin Arthritis Rheum; 2010 Feb; 39(4):294-312. PubMed ID: 18823646 [TBL] [Abstract][Full Text] [Related]